NEWPORT BEACH, CA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) CEO, Darren Cherry, stated last week that he foresees 20% quarter over quarter revenue growth for the foreseeable future. Today, he announced that a new development will result in a much larger revenue jump in the current quarter.
“Our quality work, excellent service, and budding relationships are paving our way,” Cherry explained. “One of our most loyal clients just quadrupled their ongoing orders.” Cherry says that the large order increases are a direct result of increased market demand. “We are seeing the marketplace respond,” Cherry continued. “When the highest quality products go into an Amster-Can, people associate our packaging and contents with a brand they can trust. This particular client went from a quarter of a pallet to a full pallet and expects that to be the regular order going forward. Our clients understand the value of having a hermetically sealed package that can be branded, labeled, and stored the way they want it.” Cherry says that this was an unexpected order that Advantis is immediately fulfilling, so he felt it necessary to update shareholders. “This is revenue we expect for the current quarter, so I thought it was important, especially since I announced a lower revenue forecast last week. With these growing relationships, comes the ability to expand more rapidly.” Cherry added that he expects more clients in the coming months to significantly increase their orders. “We had a surge of new clients not too long ago that wanted to try us out. I think this is the first of many unexpected orders to come in as our clients see success and our brand and marketing reach expands with current and new partners.
Cherry says that the company is currently negotiating with a privately held potency and genetic testing company and an online platform, StrainRX.co, to be able to provide additional services to their client base. “We are always asked about it and we will hopefully be able to provide the essential product testing required here in the state of California and beyond. We will be able to expand our product offerings to include everything related to testing, branding, and marketing so that the master growers we work with can focus on doing what they do best: cultivating the highest quality cannabis out there.” Cherry touched on negotiations with StrainRX and alluded to a special relationship they are developing. “These guys know their stuff. They’ve catalogued and detailed just about every strain in existence and have an encyclopedic database of what each strain does or doesn’t do. If you are looking for something that will make you relaxed, reduce stress, and reduce anxiety, then you can tell it and its database will tell you the exact strains you should look for and even show you where to get it. This is next level.” Cherry was scant on details but concluded that building a relationship with the company fits perfectly within the company vision and business plan. “We are adding to our marketability,” he said. “I can’t say exactly what we are negotiating about, but I can say that it will significantly add to our marketing footprint.”
Advantis wishes to thank Investors Hangout for mentioning the company in their podcast.
Links to Advantis pictures and websites can be found on Facebook and Instagram pages, and at advantiscorp.com, rosin6.com, elixicure.com, and amstercan.com.
About Advantis Corporation
Advantis Corporation (ADVT) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company additionally establishes partnerships with businesses that develop and sell proprietary pain management, and consumer products and services.
Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Forward- looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.